SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-08-039011
Filing Date
2008-07-08
Accepted
2008-07-08 16:02:30
Documents
3
Period of Report
2008-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v119373_8k.htm 8-K 26591
2 v119373_ex10-1.htm EX-10.1 318921
3 v119373_ex10-2.htm EX-10.2 130920
  Complete submission text file 0001144204-08-039011.txt   478065
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13441 | Film No.: 08943026
SIC: 2836 Biological Products, (No Diagnostic Substances)